▮ DFV TERMINAL
--:--:-- UTC SIGN IN
F1 Terminal / JNGHF

JNGHF — Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR

—
OTC · Unknown · Unknown · CIK 2071868 · China
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. The company develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.
No quarterly fundamentals indexed for this ticker.

Yahoo Snapshot (yfinance, live)

Total Revenue
$32,564,369,408
EBITDA
$9,452,852,224
Free Cash Flow
$6,307,738,624
Enterprise Value
$7,410,251,264
Total Cash
$40,635,797,504
Total Debt
$67,474,744
Shares Out
—
Trailing EPS
—
Book Value
$1.40
ROE
14.5%
ROA
8.8%
Div Yield
—

Peers — same industry

TickerNameMarket CapLastDaily %
KLAC KLA CORP $332.50B $254.54 —
KXIAY Kioxia Holdings Corporation/ADR $288.33B $52.80 —
IBM INTERNATIONAL BUSINESS MACHINES CORP $255.87B $272.24 —
TMO THERMO FISHER SCIENTIFIC INC. $174.42B $469.34 —
SMERY Siemens Energy AG/ADR $150.30B $176.65 —

News headlines (Yahoo Finance, 1h cache)

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026
2026-06-05 23:32 · Yahoo
Kailera’s three-pronged obesity shot shows promise in early trial
2026-05-27 11:45 · Yahoo
A Look At Bristol Myers Squibb (BMY) Valuation After Major Hengrui Collaboration Announcement
2026-05-15 09:15 · Yahoo
Bristol-Myers Strikes $15.2 Billion China Drug Deal
2026-05-13 12:57 · Yahoo
Hengrui Pharma and Kailera Therapeutics Announce Clinical Data Presentations at the American Diabetes Association 86th Scientific Sessions
2026-05-13 11:30 · Yahoo
BMS and Hengrui forge $15.2bn alliance for early-stage drugs
2026-05-12 15:10 · Yahoo
Bristol Myers Squibb signs $15.2B licensing deal with Hengrui
2026-05-12 13:48 · Yahoo
Bristol Myers Squibb Expands Pipeline With Hengrui Multi Billion Drug Alliance
2026-05-12 11:15 · Yahoo
Bristol Myers, Hengrui join forces in drugmaking alliance worth up to $15.2 billion
2026-05-12 08:18 · Yahoo
Bristol-Myers Squibb, Hengrui Pharma Sign Drug Development Deal Worth Up to $15.2 Billion
2026-05-12 07:58 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.
SEC EDGAR filings → · StockAnalysis.com → · OpenInsider →